Menu

Menu

/

/

Newsflash

Newsflash

August 3, 2021

December 2020

Share:

*|MC:SUBJECT|*

View this email in your browser

Submit your abstract for our Annual Meeting!
Reminder: deadline for abstract submission is tomorrow at 23.59h.

Abstracts should be submitted via email. Two types of abstract can be submitted: a ‘classic abstract’ and a ‘project abstract’. More information can be found here.

Don’t hesitate to forward this e-mail to your colleagues!

Copyright © 2019 Glioma MR Imaging 2.0, All rights reserved.
You are receiving this email because you opted in via our website or have expressed an interest in our COST Action.

Add us to your address book

Want to change how you receive these emails?
You can subscribe, update your preferences or unsubscribe from this list.

This email was sent to *|EMAIL|*
why did I get this? unsubscribe from this list update subscription preferences
*|LIST:ADDRESSLINE|*

*|REWARDS|*

Recent News

A guide to advanced MRI processing

PREPRINT AND POSTER ARE OUT NOW

GliMR2.0 continues... as a working group of ESMRMB

SUBMIT YOUR ABSTRACT NOW!

Attention Early Career Researchers: Join MAGMA as Guest Editors for Special Issue 2025!

February 7, 2024

POSITIONS AVAILABLE FOR EARLY CAREER RESEARCHERS AS A GUEST EDITOR ON A MAGMA SPECIAL ISSUE IN 2025

Follow Us

COST

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.

COST Action CA18206

This COST Action aims to build a pan-European and multidisciplinary network of international experts in glioma research, patient organisations, data scientists, and MR imaging scientists by uniting the glioma imaging community within Europe and progressing the development and application of advanced MR imaging for improved decision making in diagnosis, patient monitoring, and assessment of treatment response in clinical trials and clinical practice.

Action Details

Memorandum of Understanding (MoU)
Start Date: 12 September 2019
End Date: 11 September 2023
CSO approval date: 4 June 2019
Email: glimrca18206@erasmusmc.nl

Subscribe Newsletter

By subscribing you agree with our Privacy Policy.

© 2020 GliMR2.0 COST Action CA18206 • Privacy Policy

Design by Boutik